Semaglutide
STEP-HFpEF
Novo Nordisk · Phase 3 · Completed · Enrollment 529
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity or overweight | n/r | 59 | ITT | n/r |
| Placebo (semaglutide) | Obesity or overweight | n/r | 59 | ITT | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Semaglutide
Novo Nordisk · Phase 3 · Completed · Enrollment 529
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity or overweight | n/r | 59 | ITT | n/r |
| Placebo (semaglutide) | Obesity or overweight | n/r | 59 | ITT | n/r |